Trials / Completed
CompletedNCT04018339
A Study of RTA 402 in Obese Adults
Phase I Study of RTA 402 in Obese Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 49 Years
- Healthy volunteers
- Not accepted
Summary
To investigate changes in body weight and body composition in obese adults after repeated oral administration of RTA 402 once daily for 16 weeks, using placebo as a control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bardoxolone methyl | Bardoxolone methyl 5 mg capsules |
| DRUG | Placebo | Capsules containing an inert placebo |
Timeline
- Start date
- 2019-08-20
- Primary completion
- 2020-05-28
- Completion
- 2020-06-18
- First posted
- 2019-07-12
- Last updated
- 2020-06-23
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04018339. Inclusion in this directory is not an endorsement.